Structural

Moderate AS With Heart Failure: UNLOAD and Beyond

9 min.

Prognostic Value of Tricuspid Valve Gradient After Transcatheter Edge-To-Edge Repair: Insights from the TriValve Registry

9 min.

Outcomes of Patients With New Left Bundle Branch Block Following Transcatheter Aortic Valve Replacement: Insights From the NCDR STS/ACC TVT Registry

18 min.

Atrioventricular Conduction System Changes During Transcatheter Aortic Valve Replacement (TAVR): Anatomic and Electrophysiologic Predictors of Heart Block in Prospective 400 Patient EPS/TAVR Study

22 min.

Trancatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis and Small Aortic Annuli: A Randomized Clinical Trial (the VIVA Trial)

21 min.

Cerebral Microbleeds During Transcatheter Aortic Valve Replacement: A Prospective Magnetic Resonance Imaging Study Cohort

10 min.

Cardiac Output, Cerebral Blood Flow and Cognitive Functioning in Patients Undergoing Transcatheter Aortic Valve Implantation

9 min.

Prophylactic Antithrombotic Therapy After TAVR

12 min.

Pharmacotherapy to Slow AS Progression and Protect the Heart

9 min.

Moderate AS With Cardiac Damage: The EXPAND TAVR II Trial

8 min.

Moderate AS With Cardiac Damage: The PROGRESS Trial

5 min.

Moderate AS With Heart Failure: TAVR UNLOAD

4 min.

EARLY TAVR

5 min.

EVOLVED: CMR As an Early Marker of Risk

6 min.

TAVR vs SAVR in Low Gradient AS: Evidence Updates

18 min.

Five-year Echocardiographic Outcomes From The PARTNER 3 Low-risk Randomized Trial

17 min.

Importance of Patient Reported Outcomes

14 min.

An Echo Deep Dive of the PARTNER 5-Year Study

13 min.

Important Secondary Endpoints From the PARTNER 3 5-YEAR STUDY

18 min.

Perspectives on Mortality in the PARNTER 5-Year Study

15 min.

ALIGN-AR Trial: Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement in High Risk Patients With Symptomatic Severe Native Aortic Regurgitation

16 min.

Four-Year Outcomes From the EVOLUT Low Risk Trial

19 min.

Five-Year Clinical and Echocardiographic Outcomes From The PARTNER 3 Low-Risk Randomized Trial

23 min.

Comparison of Two Self-Expanding Transcatheter Heart Valves for Degenerated Surgical Bioprostheses: The AVENGER Multi-Center Registry

12 min.

TAVR Explant: What Every Interventionalist (and Surgeon) Needs to Know

8 min.

Bioprosthetic Valve Failure and Durability—Does TAVR Really Outperform SAVR?

8 min.

Surgical ADVANCEMENTS in Aortic Valve Regurgitation: When to… Repair vs. Ross vs. Replace with Root Management?

10 min.

Intersection of Guidelines and Clinical practice : Meaningful Guardrails Provide a Necessary Framework

7 min.

Update on the Evidence – Registries are Enough

6 min.

Optimal Anti-Thrombotic Therapy After TAVR – Updates and Controversies

10 min.